BACKGROUND: Over the last 12 years, the demographic and clinical characteristics of patients undergoing myocardial revascularization surgery have evolved rapidly. The goal of our study was to analyze the evolution of these trends and the results of these surgical interventions. METHODS: We identified patients who underwent a first or second myocardial revascularization between 1993 and 2004, and we arbitrarily divided them into 2 groups: 1 cohort of patients who underwent surgery between 1993 and 1998 and 1 cohort of patients who underwent surgery between 1999 and 2004. We compared demographic and clinical characteristics between the 2 cohorts and determined which variables were significant predictors of morbidity and mortality. RESULTS: From 1993 to 2004, 12 202 patients underwent a first (95.5%) or second (4.5%) myocardial revascularization. Patients in the later cohort presented with a high-risk profile. They were older and had metabolic syndrome or diabetes and peripheral vascular disease. On the other hand, there were fewer active smokers in this group. Whereas the rate of postoperative infarction and renal insufficiency was higher in the second cohort, this group had a lower incidence of stroke and prolonged mechanical ventilation and shorter hospital stays. Overall, observed mortality decreased in spite of a steady increase in predicted mortality. Identified predictors of mortality were age, stroke, female sex, nonelective surgery, renal insufficiency, peripheral vascular disease, chronic obstructive pulmonary disease, ventricular dysfunction and stenosis of the left main trunk. CONCLUSION: Our study confirmed current trends that show an increase in the at-risk population with dysmetabolic syndrome in cardiac surgery, as well as constant improvements in tertiary care in anesthesia and coronary surgery.
BACKGROUND: Over the last 12 years, the demographic and clinical characteristics of patients undergoing myocardial revascularization surgery have evolved rapidly. The goal of our study was to analyze the evolution of these trends and the results of these surgical interventions. METHODS: We identified patients who underwent a first or second myocardial revascularization between 1993 and 2004, and we arbitrarily divided them into 2 groups: 1 cohort of patients who underwent surgery between 1993 and 1998 and 1 cohort of patients who underwent surgery between 1999 and 2004. We compared demographic and clinical characteristics between the 2 cohorts and determined which variables were significant predictors of morbidity and mortality. RESULTS: From 1993 to 2004, 12 202 patients underwent a first (95.5%) or second (4.5%) myocardial revascularization. Patients in the later cohort presented with a high-risk profile. They were older and had metabolic syndrome or diabetes and peripheral vascular disease. On the other hand, there were fewer active smokers in this group. Whereas the rate of postoperative infarction and renal insufficiency was higher in the second cohort, this group had a lower incidence of stroke and prolonged mechanical ventilation and shorter hospital stays. Overall, observed mortality decreased in spite of a steady increase in predicted mortality. Identified predictors of mortality were age, stroke, female sex, nonelective surgery, renal insufficiency, peripheral vascular disease, chronic obstructive pulmonary disease, ventricular dysfunction and stenosis of the left main trunk. CONCLUSION: Our study confirmed current trends that show an increase in the at-risk population with dysmetabolic syndrome in cardiac surgery, as well as constant improvements in tertiary care in anesthesia and coronary surgery.
Authors: Alexandre C Ferreira; Arley A Peter; Tomas A Salerno; Hooshang Bolooki; Eduardo de Marchena Journal: Ann Thorac Surg Date: 2003-02 Impact factor: 4.330
Authors: John R Liddicoat; Ralph De La Torre; Kalon K L Ho; Senthil Nathan; Sidney Levitsky; Judy Krempin; Frank Sellke Journal: Ann Thorac Surg Date: 2006-04 Impact factor: 4.330
Authors: T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover Journal: Ann Thorac Surg Date: 2002-02 Impact factor: 4.330
Authors: V H Thourani; W S Weintraub; B Stein; S S Gebhart; J M Craver; E L Jones; R A Guyton Journal: Ann Thorac Surg Date: 1999-04 Impact factor: 4.330
Authors: K M Detre; P Guo; R Holubkov; R M Califf; G Sopko; R Bach; M M Brooks; M G Bourassa; R J Shemin; A D Rosen; R J Krone; R L Frye; F Feit Journal: Circulation Date: 1999-02-09 Impact factor: 29.690
Authors: K Balderas-Muñoz; H Rodríguez-Zanella; J F Fritche-Salazar; N Ávila-Vanzzini; L E Juárez Orozco; J A Arias-Godínez; O Calvillo-Argüelles; S Rivera-Peralta; J C Sauza-Sosa; M E Ruiz-Esparza; E Bucio-Reta; A Rómero; N Espinola-Zavaleta; B Domínguez-Mendez; M Gaxiola-Macias; M A Martínez-Ríos Journal: Int J Cardiovasc Imaging Date: 2017-05-09 Impact factor: 2.357
Authors: John A Dodson; Yun Wang; Mayur M Desai; Jose Augusto Barreto-Filho; Lissa Sugeng; Sabet W Hashim; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2012-05-10
Authors: Amy Johnston; Thierry G Mesana; Douglas S Lee; Anan Bader Eddeen; Louise Y Sun Journal: J Am Heart Assoc Date: 2019-08-23 Impact factor: 5.501